Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › amisulpride

amisulpride

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of amisulpride

4 trials tracked of amisulpride: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 1 citation.

4Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 1 3
  1. Phase 4 Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic Depression Completed · 1 cited
  2. Phase 1 An Investigation of Early Life Stress and Depression Completed
  3. Phase 1 Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa Completed
  4. Phase 1 The Effects of Dopamine on Reward Processing Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Aripiprazole linked to less insight improvement than dopamine antagonists in schizophrenia trial
Psychiatry RCT
Aripiprazole linked to less insight improvement than dopamine antagonists in schizophrenia trial Can reducing symptoms help people with schizophrenia gain insight into their illness?
A 6-week RCT of 144 schizophrenia spectrum disorder patients found symptom reduction was associated with improved clinical insight.
Reducing symptoms helps people with schizophrenia gain insight into their illness, but early improvement in hallucinations and delusions mat…
Apr 7, 2026